Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
Clinical trial NCT06862284 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06862284
- Sponsor
- Peking University People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-10
- Primary completion
- 2026-12-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.